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Background: The research literature has documented age-related increases in genetic damage, including oxidative
DNA damage, in human T lymphocytes, in vitro and ex vivo. Such damage has the potential to interfere with the
ability of the T cells to proliferate at times when they need to, such as when antigen challenged. The consequence
of this could be a sub-optimal immune response in vivo.
Context and purpose: The purpose of the research reported in this paper was to investigate the impact of two
antioxidants, which can be administered in vivo, Ebselen and N-acetyl L-cysteine, on the age-related increase in
genetic damage, and on T cell proliferation and lifespan. In vitro human T cell clones, ex vivo peripheral blood
mononuclear cells or T cells were supplemented with different concentrations of antioxidants, under standard
conditions and for different periods of time. A range of assays were then applied in order to determine any impact
of the antioxidants.
Results: 30 μM ebselen or 7.5 mM N-acetyl L-cysteine supplementation resulted in a significantly higher
intracellular GSH: GSSG ratio. This increased ratio was accompanied by reduced levels of oxidative DNA damage in
established CD4+ human T cell clones, from a young or a middle-aged donor. Additionally, cultures of primary
human peripheral blood mononuclear cells and CD4+ T cells from donors aged 25–30 or 55–60 years were also
supplemented with these agents. Cells from all sources exhibited increased proliferation, and in the case of the
T cell clones, an increase in cumulative population doublings. Neither ebselen nor N-acetyl L-cysteine had such
effects on clones supplemented from the midpoint of their in vitro lifespan.
Conclusions: Ebselen and N-acetyl L-cysteine, under certain conditions, may have anti-immunosenescent potential
in T cells in in vitro clonal and ex vivo polyclonal culture models.
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Previous work has revealed an age-associated increase in
DNA damage in human peripheral blood-derived T cell
clones (TCCs) in vitro under 20% O2 tension culture con-
ditions [1]. DNA damage levels and mutation frequency
have also been shown to be increased with age in poly-
clonal human lymphocytes [2]. T cell function is known to
decline with age, associated with increased susceptibility
to infection, cancer and a variety of diseases. Naive/mem-
ory T cells need to undergo rapid clonal expansion on* Correspondence: yvonne.barnett@ntu.ac.uk
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distribution, and reproduction in any mediumcontact with their specific antigen, for which they carry
unique antigen receptors, to generate an effective immune
response. DNA damage, which can result in cell cycle ar-
rest and/or apoptosis, may impact on the effectiveness of
an immune response, by interfering with clonal expansion.
Reactive oxygen species (ROS), from a wide variety of in-
trinsic and extrinsic sources, are a major cause of DNA
damage in vivo [3]. ROS have been implicated in several
human degenerative diseases of ageing [4]. T cells are also
exposed to high concentrations of ROS and reactive nitro-
gen intermediates, produced as a normal consequence of
an immune response, at sites of inflammation. In vivo
levels of antioxidants and DNA repair mechanismsntral Ltd. This is an Open Access article distributed under the terms of the
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counteract ROS-induced DNA damage [5]. An age-related
decline of DNA repair capacities has been previously
reported in CD4+ TCCs cultured in vitro in 20% O2 ten-
sion [6,7]. Here, we set out to determine the potential of
the antioxidants 2-phenyl-1,2-benzisoselenazol-3 (2H)-one
(ebselen) and N-acetyl L-cysteine (NAC) to protect T cells
from the damaging effects of ROS.
Ebselen is a synthetic, lipid soluble seleno-organic
compound having potent antioxidant capacity. It is also
a novel anti-inflammatory agent having glutathione-
peroxidase like activity, first described in 1984 [8]. NAC
is an antioxidant containing an acetylated form of the
amino acid L-cysteine that functions as a precursor of
glutathione synthesis. Glutathione is an important thiol
involved in cellular detoxification [9]. The presence of
sulfhydryl groups in NAC also enables the neutralisation
of free radicals. Previous publications have reported on
the ability of ebselen to protect HepG2 cells [8], human
HL-60 [10] and PC-12 cells [11] against H2O2 induced
cell death and DNA damage.
This investigation revealed that certain concentrations
of these antioxidants resulted in significant ROS scaven-
ging in T cell samples ex vivo irrespective of the age group
of the donors, but in TCCs, only when supplemented from
a young in vitro age.
Results
The impact of ebselen or NAC on in vitro proliferative
capacity and lifespan of CD4+ TCCs and proliferation
capacity of human PBMCs and CD4+ T cells ex vivo
The effect of different concentrations of ebselen or NAC
supplementation, from an early in vitro age (34.5 and 31.0
PD), on the proliferative capacity and in vitro lifespan of
the 400–23 and 385–7 TCCs was investigated. The results
in Table 1 show that supplementation of either 400–23 or
385–7 TCCs with 30 μM ebselen, 5 or 7.5 mM NAC, from
a young in vitro age, resulted in a higher number of PDs
per week and a significant increase in lifespan (cumulative
PD; not significant following 5 mM NAC) of the TCCs,
compared to non-supplemented clones. Neither 10 μM
ebselen nor 1.25 mM NAC had any significant impact on
the average number of PDs/week or the lifespan of CD4+
TCCs derived from donors of either age group, compared
to non-supplemented clones.
When the TCCs were supplemented from later points
in their in vitro lifespan (58.7 and 63.4 PD) the analyses
revealed marginal or no increase in proliferative capacity
or lifespan, compared to control clones. Higher concen-
trations of ebselen (60-100 μM) or NAC (10 mM)
inhibited the growth of CD4+ TCCs derived from either
age group of donors (Table 1).
Figure 1, A and C, shows a significant increase (Student’s
t-test, 95% confidence levels) in the proliferative capacity ofhuman PBMCs from donors in the 25–30 years age group
after the second week of supplementation ex vivo with
30 μM ebselen or 7.5 mM NAC, compared to non-
supplemented cells. In experiments with separated CD4+ T
cells, there was an increase in proliferative capacity, which
reached statistical significance at both 1 and 2 weeks of
supplementation with 30 μM ebselen or 7.5 mM NAC
(Figure 1, B and D). Experiments on the PBMCs and CD4+
T cells from donors aged 55–60 years revealed that 30 μM
ebselen or 7.5 mM NAC significantly increased (Student’s
t-test, 95% confidence levels) the proliferative capacity
(Figure 2A-D). 30 μM ebselen (Figure 2A and B) signifi-
cantly increased the proliferative capacity after both 1 and
2 weeks of supplementation in human PBMCs and CD4+ T
cells. 7.5 mM NAC did so only after the second week of
supplementation (Figure 2C). In CD4+ T cells (Figure 2D),
7.5 mM NAC supplementation resulted in a significant in-
crease in proliferative capacity after both 1 and 2 weeks of
supplementation. The results obtained following supple-
mentation of the PBMCs or CD4+ T cells (from either age
group of donors) ex vivo with 5 mM NAC were not signifi-
cantly different to the results obtained for 7.5 mM NAC.
The impact of each antioxidant on primary cultures of hu-
man PBMCs and CD4+ T cells, from either donor age
group, was not significantly different. The number of live
cells was too low after three weeks of culture of either
PBMCs or CD4+ T cells ex vivo to carry out any analysis.
Furthermore, the proliferative capacity observed for the
PBMCs or CD4+ Tcells derived from each of the five differ-
ent donors in each of the above cases was not significantly
different during the three week ex vivo culture period.
The impact of ebselen or NAC on redox status and total
glutathione levels in human CD4+ TCCs in vitro, PBMCs
and CD4+ T cells ex vivo
The effects of different concentrations of ebselen or
NAC on intracellular redox status (GSH: GSSG ratio)
and total glutathione levels in long-term cultured TCC
and primary cultures of PBMCs and CD4+ T cells was
determined at various time points. Figure 3 (A and B)
shows the effects of supplementing the TCC 400–23,
from an early in vitro age, with 30 μM ebselen or
7.5 mM NAC on GSH: GSSG ratio. The GSH: GSSG ra-
tio was determined at various time points (cumulative
population doublings) during the in vitro lifespan of
400–23. In contrast, Figure 3 (C and D) shows the ef-
fects of supplementation, from a later stage in the
in vitro lifespan, with 30 μM ebselen or 7.5 mM NAC
on the GSH: GSSG ratio. Supplementation from a young
in vitro age with 30 μM ebselen (Figure 3A) or 7.5 mM
NAC (Figure 3B) resulted in a higher GSH: GSSG ratio,
when compared to non-supplemented, that reached stat-
istical significance after 14 weeks. A similar set of results
was obtained in a clone derived from a middle aged
Table 1 Impact of 30 μM ebselen or 7.5 mM NAC on proliferative capacity and lifespan of TCC supplemented from a
young in vitro age
Clone (Age of the donor) Initial PD Concentration Average PD per week Cumulative PD achieved
at the end of lifespan in culture
400-23 (26 year old donor) 34.5 Control 0.7 44.9
400-23 (26 year old donor) 34.5 10 μM ebselen 0.8 46.9
400-23 (26 year old donor) 34.5 30 μM ebselen 1.2 56.2*
400-23 (26 year old donor) 34.5 60 μM ebselen Inhibited growth after one week in culture 34.5
400-23 (26 year old donor) 34.5 80 μM ebselen Inhibited growth after one week in culture 34.5
400-23 (26 year old donor) 34.5 100 μM ebselen Inhibited growth after one week in culture 34.5
400-23 (26 year old donor) 34.5 Control 0.9 49.1
400-23 (26 year old donor) 34.5 1.25 mM NAC 0.8 48.4
400-23 (26 year old donor) 34.5 5 mM NAC 1.1 53.5
400-23 (26 year old donor) 34.5 7.5 mM NAC 1.2 56.1*
400-23 (26 year old donor) 34.5 10 mM NAC Inhibited growth after two weeks in culture 35.8
385-7 (45 year old donor) 31.0 Control 0.9 44.4
385-7 (45 year old donor) 31.0 10 μM ebselen 0.9 44.9
385-7 (45 year old donor) 31.0 30 μM ebselen 1.4 50.8*
385-7 (45 year old donor) 31.0 60 μM ebselen Inhibited growth after one week in culture 31.0
385-7 (45 year old donor) 31.0 80 μM ebselen Inhibited growth after one week in culture 31.0
385-7 (45 year old donor) 31.0 100 μM ebselen Inhibited growth after one week in culture 31.0
385-7 (45 year old donor) 31.0 Control 1.0 47.2
385-7 (45 year old donor) 31.0 1.25 mM NAC 1.0 48.7
385-7 (45 year old donor) 31.0 5 mM NAC 1.3 52.8
385-7 (45 year old donor) 31.0 7.5 mM NAC 1.4 55.8*
385-7 (45 year old donor) 31.0 10 mM NAC Inhibited growth after one week in culture 31.0
Values statistically different from their controls (Student’s t-test, 95% confidence level) are indicated with an asterisk. * p < 0.05, Significantly higher than the
proliferative capacity of non-supplemented cells.
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7.5 mM NAC (Figure 3D) supplementation from later
stages of the in vitro lifespan did not have any measur-
able impact on the GSH: GSSG ratio. A similar set of re-
sults was obtained in a TCC, derived from a 45 year old
donor, when supplemented with ebselen or NAC from a
later stage of its in vitro lifespan (Figure 4C and D).
There were no quantitative significant differences in the
GSH: GSSG ratio in TCCs derived from a young donor
(400–23) compared to the ratio in clones derived from a
middle aged donor (385–7 clones). Testing other doses
of ebselen or NAC on GSH: GSSG ratio in TCCs re-
vealed that neither 10 μM ebselen nor 1.25 mM NAC
significantly altered the GSH: GSSG ratio.
Figures 5 and 6 show the results of the effect of 30 μM
ebselen (Figures 5A and B, 6A and B) or 7.5 mM NAC
(Figures 5C and D, 6C and D) on the GSH: GSSG ratio
at different culture time points of human PBMCs or
CD4+ T cells derived from healthy 25–30 or 55–60 year
olds. Figure 5A shows a significantly higher GSH: GSSG
ratio in human PBMCs derived from 25–30 year old do-
nors after two weeks of supplementation with 30 μMebselen, compared to non-supplemented cells. This pat-
tern was similar following 7.5 mM NAC supplementa-
tion of CD4+ T cells (Figure 5D). Figure 5 (B and C)
shows a significantly higher GSH: GSSG ratio in CD4+ T
cells and human PBMCs after one and two weeks of
supplementation with 30 μM ebselen or 7.5 mM NAC,
respectively, compared to non-supplemented cells. The
results obtained for PBMCs or CD4+ T cells from
55–60 year old donors, also showed that 30 μM ebselen
supplementation significantly increased the levels of
GSH: GSSG ratio after one and two weeks of supple-
mentation (Figure 6A and B). 7.5 mM NAC supplemen-
tation significantly increased the levels of GSH: GSSG
ratio after 2 weeks (Figure 6C and D).
There were no significant differences between the
GSH: GSSG ratio in cells from donors aged 25–30 years
and the ratio in cells from donors aged 55–60 years.
Also, there were no significant differences in the result-
ant GSH: GSSG ratios in PBMCs or CD4+ T cells
supplemented with 5 mM NAC or 7.5 mM NAC (results
not shown). Furthermore, individual GSH: GSSG ratios
measured in human PBMCs and CD4+ T cells ex vivo
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Figure 1 The impact of 30 μM ebselen or 7.5 mM NAC on the proliferation capacity in human PBMCs or CD4+ T cells ex vivo isolated
from fresh human blood derived from five different healthy donors, in the age group of 25–30 years supplemented ex vivo for three
weeks. A & C denotes the impact in human PBMCs and B & D denotes the impact on CD4+ T cells. The bars indicate the mean ± S.D. Values
statistically different from their controls (Student’s t-test, 95% confidence level) are indicated with an asterisk. * p < 0.05, ** p < 0.01, *** p < 0.001 -
Significantly higher than the proliferative capacity of non-supplemented cells.
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the above cases were not significantly different.
The results obtained for the measurement of total
intracellular glutathione levels in the TCCs revealed that
none of the concentrations of ebselen or NAC had any
significant impact on total glutathione levels, compared
to non-supplemented clones, either when supplemented
from an early in vitro age or from a later point in the
in vitro lifespan (results not shown). In contrast, 30 μM
ebselen or 7.5 mM NAC supplementation significantly
increased the total glutathione levels in primary cultures
of PBMCs and CD4+ T cells from donors of either age
group. 5 mM and 7.5 mM NAC supplementation had very
similar effects on total intracellular glutathione levels.
There were no significant differences between the total
glutathione levels in cells from donors aged 25–30 years
compared to cells from donors aged 55–60 years. Further-
more, the results did not reveal any differences in total
glutathione levels between individual PBMCs and CD4+ T
cell samples from each of the five different donors (results
not shown).The impact of ebselen or NAC on levels of oxidative DNA
damage in human CD4+ TCCs as a function of in vitro
age, human PBMCs and CD4+ T cells ex vivo
Aliquots of TCC samples were taken from culture at differ-
ent time points and the effect of different concentrations
of ebselen or NAC on the levels of oxidative DNA damage
within the cells was determined using the Comet assay. In
control samples, levels of oxidative damage to DNA in-
creased as a function of in vitro age, in line with previously
published findings [1,5]. Figures 7 and 8 (A and B) depicts
the impact of 30 μM ebselen (7A and 8A) or 7.5 mM NAC
(7B and 8B) on the levels of oxidative DNA damage in hu-
man CD4+ TCCs in vitro supplemented from a young
in vitro age. The results show an increase in levels of oxi-
dative DNA damage with time in culture, in both
supplemented and non-supplemented clones. Supple-
mented clones had undergone more PDs after each sam-
pled week of culture than non-supplemented clones when
supplemented from a young in vitro age. When compared
to non-supplemented clones, supplementation from a
young in vitro age with 30 μM ebselen (7A and 8A) or
Figure 2 The effect ex vivo supplementation for three weeks with 30 μM ebselen or 7.5 mM NAC on the proliferation capacity of
human PBMCs (A and C) or CD4+ T cells ex vivo isolated from fresh human blood derived from five different healthy donors aged
55–60 years. A & B denotes the effect of 30 μM ebselen and C & D denotes the effect of 7.5 mM NAC. The bars indicate the mean ± S.D. Values
statistically different from their controls (Student’s t-test, 95% confidence level) are indicated with an asterisk. ** p < 0.01, *** p < 0.001 -
Significantly higher than the proliferative capacity of non-supplemented cells.
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differences in the levels of oxidative DNA damage after
one, five and nine weeks of culture, in the TCCs derived
from either age group of donors. The reduction in levels of
oxidative damage to DNA in supplemented clones reached
statistical significance after fourteen weeks of culture.
The impact of other doses of ebselen or NAC on the
levels of oxidative DNA damage was investigated. Nei-
ther 10 μM ebselen nor 5 mM NAC significantly altered
the levels of oxidative DNA damage in CD4+ TCCs de-
rived from a healthy 26 year old donor or a healthy 45 year
old donor, compared to non-supplemented clones for any
of the four time points investigated.
Figures 7 and 8 (C and D) show the impact of 30 μM
ebselen (7C and 8C) or 7.5 mM NAC (7D and 8D) on
the levels of oxidative DNA damage in human CD4+
TCCs in vitro supplemented from the later stages of
their in vitro lifespan. In the case of TCC supplementa-
tion from the later stages of in vitro lifespan, no reduc-
tions in the levels of oxidative DNA damage, at the any
of the time points examined, were found. Levels of oxi-
dative DNA damage increased with increase of time in
culture in both supplemented and non-supplementedclones. The non-supplemented clones underwent more
PDs, compared to supplemented clones, at each of the
weekly sampling points.
There were no significant differences in the levels of
oxidative DNA damage, or in the extent of the impact of
the antioxidants in TCCs derived from a young donor
when compared with the cells from a middle aged donor
(Figures 7 and 8 A, B, C and D).
Figures 9 and 10 show the results of the effect of
30 μM ebselen or 7.5 mM NAC on levels of oxidative
DNA damage at different time points during a three
week ex vivo culture period of human PBMCs and CD4+
T cells derived from healthy donors aged 25–30 years
(Figure 9) or 55–60 years (Figure 10). The results shown
in Figure 9 show a significant decrease (Student’s t-test,
95% confidence levels) in levels of oxidative damage to
DNA in PBMCs and CD4+ T cells ex vivo isolated from
donors aged 25–30 years after two weeks of supplemen-
tation with 30 μM ebselen or 7.5 mM NAC, compared
to non-supplemented cells. A similar antioxidant effect
was revealed after 2 weeks of supplementation of cells
derived from 55–60 year old donors (Figure 10). The ef-
fect of 5 mM NAC supplementation of human PBMCs
Figure 3 The effect of 30 μM ebselen or 7.5 mM NAC on intracellular GSH: GSSG ratio in the human CD4+ TCC 400–23 when
supplemented from a young in vitro age or from a later time point in the in vitro lifespan. A & B denotes the impact of either antioxidant
supplemented from a young in vitro age and C & D denotes the impact of these antioxidants when supplemented from the later stages of their
in vitro lifespan. The bars indicate the mean ± S.D. Values statistically different from their controls (Student’s t-test, 95% confidence level) are
indicated with an asterisk. * p < 0.05 - Significantly higher than the ratio of non-supplemented cells.
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NAC supplementation in cell samples derived from do-
nors of either age group (results not shown). In all cases,
levels of oxidative damage to DNA increased as a func-
tion of time in culture. There were no significant differ-
ences in individual cell sample levels of oxidative DNA
damage from the different donors or donor group ages.
Discussion
In this study, the impact of the antioxidants, ebselen and
NAC, on established monoclonal CD4+ T cell cultures and
primary cultures of human PBMCs and CD4+ T cells has
been investigated. The impact of age (in vitro lifespan)
and/or age of cell donor on markers of T cell integrity and
function (DNA damage and cell proliferation) was
examined.
Supplementation of CD4+ TCCs, derived from a
healthy 26 year old donor (400–23) and a healthy 45 year
old donor (385–7) with 30 μM ebselen or 7.5 mM NAC(Table 1) from a young in vitro (34.5 – 31.0 Initial PD)
age significantly extended their lifespan. TCCs derived
from a healthy 26 year old donor and a healthy 45 year
old donor supplemented with 30 μM ebselen had cumu-
lative PDs of 56.2 and 50.8 respectively compared to
PDs 44.9 and 44.4 in non-supplemented clones. 7.5 mM
NAC supplementation enabled the TCCs from a healthy
26 year old donor and a healthy 45 year old donor to ex-
tend their lifespan evidenced by their cumulative PDs
(56.1 and 55.8 respectively) compared to the non-
supplemented clones (cumulative PDs 49.1 and 47.2).
The impact of supplementation on intracellular redox
status (GSH: GSSG ratio) and total glutathione levels
was determined. Intracellular redox status is an import-
ant mechanism having an invaluable role as a mediator
in apoptosis in many cell systems [12]. The GSH: GSSG
redox couple maintains the redox environment of the
cell and GSH is abundant in the cell [13] serving as an
indicator of the cellular redox environment. Redox
Figure 4 The effect of 30 μM ebselen or 7.5 mM NAC on intracellular GSH: GSSG ratio in the human CD4+ TCC 385–7 when
supplemented from a young in vitro age or from a later time point in the in vitro lifespan. A & B denotes the impact of either antioxidant
supplemented from a young in vitro age and C & D denotes the impact of these antioxidants when supplemented from the later stages of their
in vitro lifespan. The bars indicate the mean ± S.D. Values statistically different from their controls (Student’s t-test, 95% confidence level) are
indicated with an asterisk. * p < 0.05 – Significantly higher than the ratio of non-supplemented cells.
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small amount of GSH. This oxidation results in the for-
mation of GSSG and mixed disulfides between protein
sulfhydryl groups in biological systems. It will also de-
crease the levels of GSH, resulting in an increase in
levels of GSSG and so lowering the GSH: GSSG ratio,
which has been suggested to be responsible for several
human diseases [14]. Supplementation with 30 μM
ebselen or 7.5 mM NAC (Figures 3 and 4, A, B) resulted
in a significantly higher GSH: GSSG ratio in the CD4+
TCCs examined. These results suggest that in the pres-
ence of this level of ebselen, intracellular radical levels
were lowered as inferred from the higher GSH: GSSG
ratio. NAC is a derivative of GSH formation, explaining
the higher GSH: GSSG ratio on supplementation. How-
ever, neither of the antioxidants significantly altered the
total glutathione levels in either of the CD4+ TCCs.
The results of the analysis of DNA damage levels in
TCCs at various point in their lifespan revealed, as has
been previously reported [15], an in vitro age-related in-
crease in DNA damage levels in non-supplemented
TCCs (Figures 7 and 8). The enhanced antioxidantstatus of the supplemented cells, higher GSH: GSSG ra-
tio on supplementation with 30 μM ebselen or 7.5 mM
NAC, was in parallel to the significant decreases in oxi-
dative DNA damage levels after 14 weeks of supplemen-
tation in CD4+ TCCs from donors of both age groups,
compared to the non-supplemented clones. These re-
sults do suggest that the DNA damaging free radical/
oxidant burden in the supplemented cells was less than
for non-supplemented cells.
Previous findings reveal that intracellular reduced
GSH levels become depleted before the onset of apop-
tosis [16]. The maintenance of GSH levels could explain
the observed delayed time to apoptosis/cell death in the
supplemented cells. This is consistent with the findings
that CD4+ TCCs in vitro self-delete via apoptosis at the
end of their in vitro lifespan.
In contrast to clones supplemented from an early
point in their in vitro lifespan, there was no significant
change to the GSH: GSSG ratio or total glutathione
levels, proliferative capacity, lifespan or oxidative DNA
damage levels, in TCCs derived from a 26 year old
donor or a 45 year old donor on supplementation from
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Figure 5 The effect of three weeks ex vivo supplementation with 30 μM ebselen or 7.5 mM NAC on the intracellular GSH: GSSG ratio in
human PBMCs or CD4+ T cells isolated from fresh human blood derived from five different healthy donors aged 25–30 years. A & B
denotes the effect of 30 μM ebselen and C & D denotes the effect of 7.5 mM NAC. The bars indicate the mean ± S.D. Values statistically different
from their controls (Student’s t-test, 95% confidence level) are indicated with an asterisk. **p < 0.01, ***p <0.001 – Significantly higher than the
ratio of non-supplemented cells.
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PD) with any of the concentrations of ebselen or NAC,
compared to the non-supplemented clones. These re-
sults were in line with the previous findings from our
group that revealed no significant changes in longevity
in CD4+ TCCs on long term culture, from the midpoint
of their in vitro lifespan, with 20 mM carnosine [5]. The
suggested reason for the failure of carnosine to reveal its
antioxidant potential may have been due to the high
background of biomolecule damage that already existed
in these T cells, accumulated during earlier stages of
their lifespan under conditions of 20% O2, that may have
decreased the antioxidant or free radical scavenging po-
tential of carnosine. Previous findings from the group of
Barnett have demonstrated an age-related increase in
levels of oxidised purine and pyrimidine bases within T
cells [1] which is in line with the findings reported here.
Greater levels of radicals in older TCCs may affect the
function of their defence systems. Published papers have
reported a decrease in other markers of T cell integrity
with age. The DNA repair capacity in T cells in vitro hasbeen shown to decline with age, revealed in previous
studies by this group [6,7]. Furthermore, Heat Shock
Protein activity has been demonstrated to decline in re-
sponse to age making the body more susceptible to
stress-induced damage [17,18].
In PBMCs and CD4+ T cells ex vivo derived from do-
nors from either age groups, supplementation with
30 μM ebselen or 7.5 mM NAC resulted in a signifi-
cantly higher GSH: GSSG ratio (Figures 5 and 6), total
glutathione levels and proliferative capacity (Figures 1
and 2) at different time points during their life in cul-
ture, compared to non-supplemented cells ex vivo. The
levels of oxidative DNA damage were significantly de-
creased after two weeks of culture in human PBMCs
and CD4+ T cells ex vivo (Figures 9 and 10), when com-
pared to non-supplemented cells ex vivo.
The significant increase in total glutathione levels on
supplementation with 7.5 mM NAC demonstrates the
ability of NAC to contribute to enhanced levels of gluta-
thione synthesis in these cells ex vivo, thereby enhancing
the intracellular antioxidant status. A significant increase
Figure 6 The effect of three weeks ex vivo supplementation with 30 μM ebselen or 7.5 mM NAC on the intracellular GSH: GSSG ratio in
human PBMCs or CD4+ T cells isolated from fresh human blood derived from five different healthy donors aged 55–60 years. A & C
denote the effect of antioxidants in human PBMCs and B & D denote the effect of antioxidants in CD4+ T cells. The bars indicate the mean ± S.D.
Values statistically different from their controls (Student’s t-test, 95% confidence level) are indicated with an asterisk. **p < 0.01, ***p <0.001 –
Significantly higher than the ratio of non-supplemented cells.
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mentation with 30 μM ebselen. Ebselen is glutathione
peroxide (GPx) mimetic. GPx has the ability to scavenge
organic and inorganic peroxides and hydroxyl radicals
using GSH as substrate, which in turn becomes depleted.
From the results reported in this paper, ebselen may have
scavenged the existing intracellular radicals, in so doing
the need for GSH to scavenge them would be lessened,
leading to higher GSH levels in the cells supplemented
with ebselen.
The results reported in this paper provide evidence for
the antioxidant potential of 30 μM ebselen or 7.5 mM
NAC, against endogenously generated oxidants and
those associated with the 95% air, 5% CO2 culture condi-
tions in human PBMCs and CD4+ T cells ex vivo. The
higher GSH: GSSG ratio represents an increased antioxi-
dant state on supplementation with ebselen or NAC.
This increase in antioxidant status helps explain the
decrease in levels of oxidative DNA damage and the
increase in proliferative capacity of the supplemented
cells. 5 mM NAC supplementation also revealed a
significant antioxidant potential, similar to supplementa-
tion with 7.5 mM NAC, in human PBMCs and CD4+
T cells ex vivo.A comparative analysis did not reveal any differences
in the effects of 30 μM ebselen or 7.5 mM NAC in hu-
man CD4+ T cells ex vivo or CD4+ TCCs in vitro in the
markers of T cell integrity and function examined. Inter-
estingly, 5 mM NAC supplementation did not reveal any
significant antioxidant potential in CD4+ TCCs in vitro,
unlike the potential demonstrated in the ex vivo
polyclonal PBMC population and CD4+ T cells ex vivo.
Human TCCs are maintained in culture throughout
their lifespan over several months. This is not the case
in cells ex vivo. It may be that the longer span of culture
in vitro altered certain aspects of the biochemical/mo-
lecular status of the cells. The in vitro TCCs may have
steadily accumulated biomolecule damage during their life-
span under conditions of 20% O2 that may have decreased
the antioxidant or free radical scavenging potential of NAC
at this specific concentration on long-term supplementa-
tion. Under these extensive culture conditions, antioxidant
or free radical scavenging effects of NAC at 5 mM concen-
trations may be insufficient to reveal any significant antioxi-
dant potential in TCCs in vitro.
The impact of long term supplementation of ebselen
or NAC has not yet been reported for other cell lines.
The previous studies investigating the impact of ebselen
Figure 7 The effect of 30 μM ebselen or 7.5 mM NAC on the levels of oxidative DNA damage in the 400–23 CD4+ TCC when
supplemented from a young in vitro age or when supplemented from a later stage in the lifespan. A & C illustrates the effect of 30 μM
ebselen and B & D illustrates the effect of 7.5 mM NAC. The bars indicate the mean ± S.D. Values statistically different from their controls
(Student’s t-test, 95% confidence level) are indicated with an asterisk. * p < 0.05, ** p < 0.01, *** p < 0.001 - Significantly higher than the levels of
DNA damage in non-supplemented cells.
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or the impact of NAC in HepG2 [19] and HeLa [22] cell
lines to name a few, revealed their potential impact only
up to 24 hours after the antioxidant supplementation.
Furthermore, in this investigation we found that higher
concentrations of ebselen (60-100 μM) or NAC
(10 mM) resulted in complete inhibition of the growth
of TCCs. It may be that higher concentrations of ebselen
or NAC scavenged intracellular oxygen free radicals to
such an extent that those necessary for the proliferative
pathways were severely/completely limited. Other stud-
ies have demonstrated a significant increase in intracel-
lular GSH depletion with an increase in ebselen
concentration in HepG2 cells [19]. Ebselen has the abil-
ity to bind with GSH to form ebselen selenyl sulphide
which reacts with excess of GSH to form a ebselen
selenol intermediate that in turn reacts with peroxides
[23]. The ebselen selenol intermediate can further react
with ebselen selenyl sulphide to form ebselen diselenide.This in turn can further react with peroxides resulting in
intracellular GSH depletion that leads to induction of
apoptosis [19] or cells succumbing to stress [24]. This
mechanism may also contribute to the complete inhib-
ition of growth of TCCs on supplementation with higher
concentrations of ebselen.
The dose- and time-dependent differences on the im-
pact of radical scavenging capacity or pro-oxidant effect
of antioxidants has been previously demonstrated [8].
Although ROS are generally thought of as harmful mole-
cules, they play an important role in T cell signalling
events such as protein tyrosine phosphorylation and ac-
tivation of JNK [25]. One of the prominent families of
protein kinases, the MAP kinases, includes ERK, JNK
(SAPK) and P38 kinase involved in proliferation, differ-
entiation and apoptosis in cells. The impact of ebselen
or NAC on these pathways in CD4+ TCCs of different
age group maintained at 20% O2 tension is currently
under investigation.
Figure 8 The effect of 30 μM ebselen or 7.5 mM NAC on the levels of oxidative DNA damage in the 385–7 CD4+ TCC when
supplemented from a young in vitro age or when supplemented from a later stage in the lifespan. A & C illustrates the effect of 30 μM
ebselen and B & D illustrates the effect of 7.5 mM NAC. The bars indicate the mean ± S.D. Values statistically different from their controls
(Student’s t-test, 95% confidence level) are indicated with an asterisk. * p < 0.05, ** p < 0.01, *** p < 0.001 - Significantly higher than the levels of
DNA damage in non-supplemented cells.
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This current study revealed that for a limited set of con-
ditions, 30 μM ebselen or 7.5 mM NAC supplementa-
tion of CD4+ TCCs (from a young in vitro age) or CD4+
T cells ex vivo enhanced the antioxidant potential of
supplemented cells through boosting the GSH: GSSG ra-
tio, resulting in a significant decrease in levels of oxida-
tive DNA damage and a significant increase in lifespan,
and/or proliferative capacity. It is suggested that the pos-
sible in vivo antioxidant potential of ebselen or NAC
should be investigated alongside their potential as anti-
immunosenescent interventive strategies.
Methods
The first part of this investigation was designed to deter-
mine the impact of a range of concentrations of ebselen
(0-100 μM) or NAC (0-10 mM) on the intracellular
redox status and on certain markers of T cell integrity
and function in a set of established CD4+ TCCs exposedto these agents at different timepoints in their in vitro
lifespan. The results obtained were then used to design
the second investigation on the impact of selected con-
centrations of ebselen or NAC on human PBMCs and in
CD4+ T cells in primary cultures.
T cell clones
The 400–23 clone was obtained from a 26 year old
overtly healthy female laboratory worker and the 385–7
clone was obtained from a 45 year old overtly healthy fe-
male laboratory worker as described previously [18]. The
TCCs, expressing αβ-T cell receptors for antigen (TCR),
CD3+, and CD4+ were separately maintained in culture
in a serum-free medium, X-Vivo 10 (Bio Whittaker), in
24 well plates (5 wells, 2 ml medium per well) at con-
centrations of 2–4 × 105 cells per well, along with 2 × 105
gamma-irradiated (80 Gy) RJK853 cells per well (EBV-
transformed B-lymphoblastoid cell line with complete
hprt deletion) as feeder cells. The TCCs were maintained
Figure 9 The effect of three weeks ex vivo supplementation with 30 μM ebselen or 7.5 mM NAC on the levels of oxidative DNA
damage in human PBMCs or CD4+ T cells ex vivo isolated from fresh human blood derived from five different healthy donors aged
25–30 years. A & B denote the impact of 30 μM ebselen and C & D denote the impact of 7.5 mM NAC. The bars indicate the mean ± S.D. Values
statistically different from their controls (Student’s t-test, 95% confidence level) are indicated with an asterisk. ** p < 0.01, *** p < 0.001 -
Significantly higher than the levels of DNA damage in non-supplemented cells.
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95% air atmosphere and supplemented with 400U/ml re-
combinant IL-2 (Chiron, UK) on days 1 and 4 of the
cycle. On day 7, a viable cell count was performed on
harvested cells using a Neubauer Counting Chamber,
and a new culture cycle was set up with fresh medium
and RJK853 feeder cells [5,15].
The number of population doublings (PDs) that the
TCCs underwent during a week in culture is referred to
as the proliferative capacity of the clone. The total num-
ber of population doublings that the TCCs underwent
during culture is defined as lifespan. A TCC has to ex-
pand up to 26 PD to have sufficient numbers for analysis
or stock reserves, due to constraints imposed by the
cloning process. The earliest stage in the lifespan of the
TCCs used in this analysis was ~ 26 PD.TCC samples, at different stages in their in vitro life-
span, were cryopreserved in a medium made up of 10%
DMSO (Sigma), 20% FBS (Invitrogen) and 70% X-Vivo
10 and stored in liquid nitrogen for further analysis at
the end of a 7 day growth cycle [5].
Subject selection, sample collection, culture and storage
of human peripheral blood mononuclear cells
This part of the investigation was granted ethical ap-
proval by Nottingham Trent University. The human
blood samples were drawn from ten healthy, non-
smoking males fasted overnight, five each from the age
groups of 25–30 years and 55–60 years. The subjects
were not on any form of medication and had not suf-
fered any recent illness. Other lifestyle factors such as al-
cohol consumption and exercise regime were also taken
Figure 10 The effect of a three week ex vivo supplementation with 30 μM ebselen or 7.5 mM NAC on the levels of oxidative DNA
damage in human PBMCs or CD4+ T cells ex vivo isolated from fresh human blood derived from five different healthy donors aged
55–60 years. A & B denote the impact of 30 μM ebselen and C & D denote the impact of 7.5 mM NAC. The bars indicate the mean ± S.D. Values
statistically different from their controls (Student’s t-test, 95% confidence level) are indicated with an asterisk. ** p < 0.01, *** p < 0.001 -
Significantly higher than the levels of DNA damage in non-supplemented cells.
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the morning between 8.00 and 9.00 am by a licensed
phlebotomist and collected in a tube containing heparin
to prevent coagulation. The samples were kept on ice
and taken to the laboratory within 5 minutes for separ-
ation of PBMCs.
PBMCs were isolated from fresh heparinised venous
blood by density gradient centrifugation on Ficoll-
Isopaque (PAA Laboratories) in LeucoSep (Lymphocyte
separation tubes). PBMCs were maintained in culture
separately using an established method [26]. PBMCs
were washed twice in phosphate-buffered saline or X-
Vivo 10 media and then maintained in culture similar to
TCCs as explained in section 5.1.Isolation of CD4+ T cells from human PBMCs
The CD4+ T Cell Isolation Kit (Miltenyi Biotech) is a mag-
netic labelling system for the isolation of CD4+ T cells from
human PBMCs. 10 × 106 human PBMCs from each of the
donor samples were separately treated with a cocktail of
biotin-conjugated antibodies against non-CD4+ T cells and
were subsequently depleted by labelling with anti-biotin
microbeads. The different cell suspensions were then
allowed to pass separately through a PBS (Oxoid Ltd) pre-
rinsed column placed in the magnetic field of a suitable
MACS separator. CD4+ T cell eluates were collected in the
bottom tube. The CD4+ T cell eluates were then washed in
phosphate buffered saline or X-Vivo 10 media and
maintained in culture separately, as described in section 5.1.
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Human PBMCs or CD4+ T cells ex vivo from donors of
different age groups, with or without the antioxidants,
were cultured separately at 1 × 106 cells per well in a 24
well plate. Tritiated thymidine was added 18 hours prior
to harvesting at a final concentration of 0.037 MBq/ml.
Cells were transferred into a 96 well plate the next day
and were harvested using a 96 well harvester onto a 96
well filter plate and 40 μl of scintillation fluid was added
to each of the filter pads. Filters were counted for 1 minute
per well with a Top-Count scintillation counter and the
amount of radioactivity incorporated (proliferation cap-
acity of the cells) was expressed in thymidine incorpor-
ation (H3) counts per minute (cpm). All the samples were
analysed in duplicate.
Ebselen or NAC supplementation
The proven ability of NAC to act as an efficient antioxi-
dant in HeLa cells [22] and HepG2 cells [8] was taken into
consideration before choosing the dose range of the anti-
oxidants in this investigation. Initial studies were carried
out by supplementing a TCC with a range of doses of
ebselen (0-100 μM; Sigma) and NAC (0-10 mM; Sigma) in
X-Vivo 10. The dose ranges of 0-30 μM for ebselen and
0–7.5 mM for NAC were then chosen for the studies in-
vestigating the impact of these antioxidants on the TCC
supplemented from a ‘young’ in vitro age. Supplementa-
tion with ebselen or NAC was on days one and four of the
weekly growth cycle. The protocol for the supplementa-
tion with these antioxidants was the same as that previ-
ously used by our group for studies on the antioxidant
carnosine [5].
The impact of a range of doses of ebselen or NAC on
the TCC was considered before investigating the bio-
logical effect of 30 μM ebselen or 5 mM/7.5 mM NAC
on human PBMCs and CD4+ T cells ex vivo.
Assessment of the GSH: GSSG ratio and total glutathione
level in human PBMCs and the TCCs
The GSH: GSSG ratio assay kit (Calbiochem) was
optimised for use in TCCs on a range of cells from 0.5 ×
106 to 3 × 106 cells/ml for assessing the levels of total
glutathione and 2 × 106 to 7 × 106 cells/ml for assessing
the levels of GSSG. A higher number of cells were used
for GSSG measurement, since it is present in such low
concentrations in human tissue. The same procedure was
carried out for human PBMCs ex vivo. The cell extracts
for analysis were prepared from harvested cells (2 × 106
cells/ml for GSH and 5 × 106 cells/ml for GSSG) according
to the manufacturer’s instructions. The GSH: GSSG ratio
and the total glutathione levels were calculated from the
GSH and GSSG concentrations of the T cells ex vivo or
in vitro, photometrically measured at 412 nM in μM con-
centrations. All the samples were analysed in duplicate.Assessment of levels of oxidative damage to DNA
The levels and types of DNA damage in T cells ex vivo
and in vitro, supplemented with or without antioxidants,
at different time points throughout their lifespan were
assessed using modified alkaline comet assay [5]. This
method has been successfully used previously to meas-
ure DNA damage in T cells [5,15].
The Comet assay is a method used to measure DNA
strand breaks in eukaryotic cells. The alkaline Comet
assay involves analysing stained cells embedded in agar-
ose in a microscopic slide using a fluorescent micro-
scope. Prior to staining, the cells are lysed with
detergent and high salt resulting in nucleoids containing
super-coiled loops of DNA linked to the nuclear matrix.
On electrophoresis, the loops containing a break loose
their super-coiling and extend towards the anode. These
loops give structures similar to comets. This technique
involves electrophoresis at high pH that results in struc-
tures similar to comets viewed using a fluorescent
microscope. The number of DNA breaks can be assessed
by quantifying the intensity of comet tail compared to
the head. The alkaline Comet assay is performed to de-
tect DNA single strand breaks and alkali-labile lesions.
The two modified Comet assays also employed in this
current investigation utilised either endonuclease III
(Endo III) or formamidopyrimidine glycosylase (FPG) to
pre-treat the cells before analysis. Endo III or FPG (both
from New England Biolabs) recognise oxidatively-
modified pyrimidines, or oxidatively-modified purines,
respectively. The enzymes create single-strand breaks by
nicking DNA at the sites of oxidatively damaged nucleo-
tides that can be detected with the comet assay.
The Comet assays were carried out at 4°C, to reduce
the amount of repair of basal/induced levels of DNA
damage. 2 × 104 cells embedded in 1% low melting point
agarose were overlaid on to an existing 1% high melting
point agarose gel in each of the frosted slides. The slides
were then maintained in a high salt alkaline lysis buffer
(2.5 M NaCl, 0.1 M EDTA, 0.01 M Tris, 1% (v/v) Triton
X-100, pH 10) for an hour in ice. After the slides were
lysed, they were equilibrated in enzyme buffer (0.04 M
HEPES, 0.1 M KCl, 0.5 mM EDTA, 0.2 mg/ml BSA,
pH 8.0) for three 5 minute washes prior to treatment
with the enzymes Endo III or FPG. The treated slides
were then incubated in a dark humid chamber at 37°C for
45 minutes. Post incubation, the slides were maintained in
electrophoresis buffer (0.3 M NaOH, 1 mM EDTA) for
40 minutes, enabling the alkaline unwinding of the DNA.
The slides were then electrophoresed in a pre-chilled tank
at 25 V, 300 mA for 20 minutes. The slides were then
neutralised with three 5 minute washes in neutralising
buffer (0.4 M Tris pH 7.5). Finally, the gels were stained
with 50 μg/ml ethidium bromide (Sigma) and digitally
analysed using a fluorescent microscope and the comet
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puter image analysis software (Komet 5.5, Andor Technol-
ogy, UK), counting 50 cells per slide. The percentage of
DNA damage in the comet tail was used as the quantita-
tive measure of DNA damage. The reagents for the assay
were purchased from Sigma. All the samples were
analysed in duplicate.
Statistical analysis of the samples
The results were tested for significance using paired
two-sample type 2 Student’s t-tests assuming equal vari-
ances; p values are presented as appropriate.
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